Dublin, ʻOkakopa 12, 2021/PRNewswire/- "Wāloaʻa ʻo Global Dermal Filler Market ma 2028-COVID-19 Impact and Global Product Analysis (Biodegradable and Non-biodegradable);Nā mea waiwai;Nā noi;Nā mea hoʻohana hope a me Geography "Ua hoʻohui ʻia ka hōʻike i nā huahana ResearchAndMarkets.com.
Ma ka makahiki 2028, e hoʻonui ʻia ke kumukūʻai o ka mākeke dermal fillers mai USD 4.39198 biliona ma 2021 a i USD 9.421.3 biliona;ua manaʻo ʻia mai 2021 a i 2028, ʻo ka nui o ka ulu ʻana o ka makahiki he 11.5%.ʻO ka ulu ʻana o ka mākeke hoʻopihapiha dermal e pili ana i ka hoʻonui ʻana i ka makemake no ka hōʻoki minimally invasive, ka ulu ʻana o ka heluna kanaka i ka makahiki 30-65, a me ka hoihoi o nā mea kūʻai aku i ka nani a me ke olakino.Eia nō naʻe, ʻo ke kumukūʻai kiʻekiʻe o ka ʻokiʻoki ke keʻakeʻa nei i ka ulu ʻana o ka mākeke.ʻO Dermal filler kahi huahana anti-aging i hoʻokomo ʻia i loko o ka ʻili o ka mea maʻi e hoʻonui i ka leo.E hoʻokuʻu iā lākou i mea e hoʻomāmā ai ka ʻili a i ʻole ka ʻili wīwī i ka makahiki.Ua kapa ʻia lākou he injectable facial fillers, injectable cosmetic fillers or soft tissue fillers.Hana ʻia lākou me ka hyaluronic acid i loaʻa mai ka momona holoholona a i ʻole ka momona hoʻomanawanui.He ʻelima mau minuke a i hoʻokahi hola e hana ai i ke kaʻina hana dermal filler.Hiki ke hoʻohana ʻia nā mea hoʻopihapiha Intradermal i ka hoʻomaʻamaʻa dermatological me nā kumukūʻai hoʻokele liʻiliʻi.Hoʻopau lākou i nā pilikia o ka nalowale o ka nui o ka helehelena a me nā laina ikaika, ʻo ia nā hōʻailona nui o ka ʻelemakule maka.Hāʻawi lākou i kahi ʻano o nā koho lapaʻau maʻalahi no nā dermatologists e hoʻokō i nā hopena kaulike a holoʻokoʻa.Ua hoʻokaʻawale ʻia ka mākeke hoʻopihapiha dermal e like me nā huahana, nā lako, nā noi, a me nā mea hoʻohana hope.Ma ka huahana, ua hoʻokaʻawale ʻia ka mākeke hoʻopihapiha dermal i biodegradable a me non-biodegradable.Manaʻo ʻia ka māhele mākeke biodegradable e noho i kahi māhele mākeke nui aʻe ma 2021, a manaʻo ʻia e hoʻopaʻa i kahi kiʻekiʻe o ka ulu ʻana o ka makahiki i ka wā wānana.Wahi a nā mea waiwai, ua hoʻokaʻawale ʻia ka mākeke hoʻopihapiha dermal i ka calcium hydroxyapatite, hyaluronic acid, collagen, poly-L-lactic acid, polymethyl methacrylate (PMMA), momona a me nā mea ʻē aʻe.Ua manaʻo ʻia e 2021, e noho ka māhele hyaluronic acid i ka māhele mākeke nui loa, a ʻo ka ʻāpana collagen e manaʻo ʻia e loaʻa ka kiʻekiʻe kiʻekiʻe o ka ulu ʻana o ka makahiki i ka wā wānana.
Wahi a ka noi, ua hoʻokaʻawale ʻia ka mākeke hoʻopihapiha dermal i ka hoʻoponopono hoʻoponopono ʻana i ka maka, ka hoʻonui ʻana i ka lehelehe, ka ʻoki plastik, ka mālama ʻana i ka scar, a me nā mea ʻē aʻe. Manaʻo ʻia ka ʻāpana e loaʻa ka helu kiʻekiʻe o ka ulu ʻana o ka makahiki i ka wā wānana.Wahi a nā mea hoʻohana hope, ua hoʻokaʻawale ʻia ka mākeke hoʻopihapiha dermal i nā keʻena dermatology, nā hale hoʻokipa multi-specialty, a me nā kikowaena o waho.Hiki i ka ʻāpana keʻena dermatology ke noho i ka māhele mākeke nui loa ma 2021. Ma ka ʻaoʻao ʻē aʻe, manaʻo ʻia ka ʻāpana o ka haukapila multi-specialty e loaʻa i ka helu kiʻekiʻe o ka ulu ʻana o ka makahiki i ka wā wānana.Ke kumu kūʻai
Ma ka ʻike ʻana i ka ulu ʻana, ka nui, nā mea pāʻani alakaʻi a me nā ʻāpana mākeke o ka mākeke hoʻopiha dermal, mālama a hoʻemi i ka manawa e hana i ka noiʻi komo.
E hōʻike i nā mea nui o ka ʻoihana e kōkua i ka ʻoihana e hoʻoponopono hou i kāna hoʻolālā ʻoihana.
ʻO nā ʻike nui a me nā ʻōlelo aʻoaʻo e hōʻike ana i nā ʻano ʻoihana holomua koʻikoʻi i ka mākeke hoʻopiha dermal honua, e hiki ai i nā mea komo ma ke kaulahao waiwai ke hoʻolālā i nā hoʻolālā lōʻihi.
Hoʻolālā / hoʻololi i nā hoʻolālā hoʻonui ʻoihana ma o ka hoʻohana ʻana i ka ulu nui ʻana i nā mākeke hoʻomohala a kū mai.
ʻO ka loiloi hohonu o nā ʻano mākeke honua a me nā manaʻo, a me nā kumu e hoʻokele ai i ka mākeke a keakea i ka ulu ʻana o ka mākeke.
E hoʻonui i ke kaʻina hana hoʻoholo ma o ka hoʻomaopopo ʻana i nā hoʻolālā e kākoʻo ana i ka makemake palekana o ka mea kūʻai aku ma ka huahana, ka ʻāpana, ke kumu kūʻai, a me ka hāʻawi ʻana.
Nā kumuhana nui i uhi ʻia: 1. Hoʻomaka 2. Dermal filler market-key point 3. Research method 4. Global Dermal Fillers Market-Market Landscape 4.1 Overview 4.2 PEST Analysis 4.2.1 North America-PEST Analysis 4.2.2 Europe-PEST Analysis 4.2. 3 Asia Pacific-PEST Analysis 4.2.4 Middle East and Africa (MEA)-PEST Analysis 4.2.5 Southern and Central America (SCAM)-PEST Analysis4.3 experts opinion5.5.1 Keaukaha makeke 5.1.1 E hoonui ana i ka makemake no ke oki invasive li'ili'i 5.1.2 Mahuahua ka heluna kanaka ma ka 30-65 makahiki 5.1.3 Hoonui i ka nani o ka mea kuai no ka nani a me ke ola kino 5.2 Kaohi kuai 5.2.1 Ke kumu kuai nui. nā kaʻina hana 5.3 Nā manawa kūʻai aku 5.3.1 Hoʻonui i ka loaʻa kālā a me ka hoʻonui ʻana i ka heluna waena waena 5.4 Nā ʻano o ka wā e hiki mai ana 5.4.1 Nā hana hoʻolālā o ka poʻe komo ma ka mākeke 5.4.2 Hoʻonui i ka helu hoʻokomo ʻana o nā mea hoʻopihapiha injectable i ka heluna kāne 5.5 Ka nānā ʻana i ka hopena 6. Makeke hoʻopiha dermal. - ka nānā ʻana o ka honua 6.1 Ka wanana a me ka nānā ʻana o ka mākeke dermal filler honua 6.2 Global dermal filler market, e ka wahi kikoʻī-no ka wānana a me ka nānā ʻana 6.3 Ke kūlana mākeke 7. Dermal Filler Market Analysis-By Product 7.1 Overview 7.2 Dermal Filler Market Revenue Share By Product (2021 a 2028) 7.3 Biodegradable 7.3.1 Manaʻo 7.3.2 Biodegradable: Dermal Filler Market-By 2028 Loaʻa a me ka wānana (Million USD) 7.4 Non-Biodegradable 7.4.1 Overview 7.4.2 Non-Biodegradable: Dermal Filler Market-Loaʻa a me ka wānana ma 2028 (Million USD)8.ʻIkepili ʻo Dermal Filler Market-8.1 ʻIke ʻia e ka Material 8.2 ʻO ka loaʻa kālā o ka mākeke Dermal Filler ma ka Material (2021 a me 2028) 8.3 Calcium Hydroxyapatite 8.3.1 Overview 8.3.2 Calcium Hydroxyapatite: Dermal Filler Market-Loaʻa a me ka wānana i 2028 (Million USD) Acid 8.4.1 Overview 8.4.2 Hyaluronic Acid: Dermal Filler Market-Revenue and Forecast to 2028 (Million USD) 8.5 Collagen 8.5 .1 Overview 8.5.2 Collagen: Dermal Filler Market-Revenue and Forecast to 2028 (Million USD) -L-lactic Acid 8.6.1 Overview 8.6.2 Poly-L-Lactic Acid: Dermal Filler Market- Loaʻa a wānana i 2028 (miliona kālā) 8.7 Polymethyl methacrylate (PMMA) 8.7.1 Overview 8.7.2 Polymethyl methacrylate (PMMA) : Ka loaʻa a me ka loaʻa kālā o ka mākeke dermal filler ma 2028 Forecast (US$ miliona) 8.8 Fat fillers 8.8.1 Overview 8.8.2 Fat fillers: dermal fillers market-loaʻa a me ka wānana e 2028 (US$ miliona) 8.9 Nā mea ʻē aʻe 8.9.1 Overview 8.9.2 Nā mea ʻē aʻe : Dermal fillers market-loaʻa a me ka wānana to 2028 (USD mika piliona) 9. Makeke hoʻopihapiha hoʻopihapiha ma o ka noi 9.1 Hōʻike 9.2 Māhele makeke hoʻopiha dermal, ma ke noi, 2021 a me 2028 (%) 9.3 Hoʻoponopono Hoʻoponopono i ke alo 9.3.1 Nānā 9.3.2 Hoʻoponopono Hoʻoponopono Laina Makeke Filler-Loaʻa a me ka wānana i 2028 (Million USD) 9.4 Hoʻonui lehelehe 9.4.1 Nānā 9.4.2 Hoʻonui lehelehe: Dermal Filler Market-2028 Ka loaʻa kālā a me ka wānana makahiki (Millions of dollars) 9.5 Facial lift 9.5.1 Overview 9.5.2 Facial hoʻokiʻekiʻe: Makeke hoʻopiha dermal-Loaʻa a me nā wanana i 2028 (Millions o nā kālā) 9.6 Hoʻomaʻamaʻa Scar 9.6.1 Nānā 9.6.2 Hoʻomaʻamaʻa Scar: Dermal Filler Market-Ka loaʻa a me ka wānana ma 2028 (Million USD) 9.7 Nā noi ʻē aʻe 9.7.1 Overview 9.7 .2 Nā noi ʻē aʻe: Dermal Filler Market-Loaʻa a me ka wānana ma 2028 (Million USD) 10. Dermal Fillers Drug Market-10.1 Overview by End User 10.2 Dermal Filler Market Share by End User, 2021 and 2028 (%) 10.3 Multi-Specialty Hospital 10.3.1 Nānā 10.3.2 Hospital: Makeke Dermal Filler-Ma ka 2028 Loaʻa a me ka wānana (Million USD) 10.4 Dermatology Clinic 10.4.1 Overview 10.4.2 Dermatology Clinic: Dermal Filler Market-Revenue and Forecast in 2028 (Million USD) 10.5 Outpatient Surgery Center Overview 10. .2 Ke kikowaena o ka maʻi maʻi: Dermal Filler Market-Loaʻa a me ka wanana o USD 2028 (Million USD) 10.6 Nā mea hoʻohana hope ʻē aʻe 10.6.1 Overview 10.6.2 Nā mea hoʻohana hope ʻē aʻe: Dermal Filler Market-Loaʻa a me ka wānana e 2028 Forecast (Millions of USD) 11. Global Dermal Fillers Market-Geographical Analysis 12. Impact of the COVID-19 pandemic on the global dermal filler market 12.1 North America: Impact assessment of the COVID-19 pandemic 12.2 Europe: Impact assessment of the COVID-19 pandemic 12.3 Asia Pacific : Impact assessment of the COVID-19 pandemic 12.4 Middle East and Africa: Impact assessment of the COVID-19 pandemic 12.5 South and Central America: Impact assessment of the COVID-19 pandemic13.ʻO nā mea hoʻopihapiha hoʻopihapiha mākeke-ʻoihana ʻāina 13.1 Nānā 13.2 Hoʻolālā ulu mākeke i hoʻokō ʻia e ka ʻoihana, (%) 13.3 Hoʻomohala kino 13.3.1 Nānā 13.4 Hoʻomohala inorganic 13.4.1 Nānā 14. Hōʻike ʻoihana 14.1 AbbVie Inc. 14.1.1 ʻO nā mea nui. ʻO ka wehewehe ʻoihana 14.1.3 Nā huahana a me nā lawelawe 14.1.4 Nānā kālā 14.1.5 Ka nānā ʻana o SWOT 14.1.6 Nā hana nui 14.2 Galderma 14.2.1 Nā mea nui 14.2.2 Nā huahana a me nā lawelawe ʻoihana wehewehe 14.14.3 2.4 Nānā kālā 14.2.5. .6 Nā hana nui 14.3 Merz Pharma 14.3.1 Nā mea nui 14.3.2 Hōʻikeʻike pāʻoihana 14.3.3 Nā huahana a me nā lawelawe 14.3.4 Nānā kālā 14.3.5 Nānā SWOT 14.3.6 Nā hana nui 14.4 Lapaʻau Suneva 14.2s1414 Key F14.214ʻO ka wehewehe ʻana i ka ʻoihana 14.4.3 Nā huahana a me nā lawelawe 14.4.4 ʻIke kālā 14.4.5 Nānā SWOT 14.4.6 Hoʻomohala Koʻikoʻi 14.5 ʻO ka lāʻau lapaʻau BIOXIS 14.5.1 ʻO nā mea nui 14.5.2 Hōʻikeʻike ʻoihana 14.5.3 Nā huahana a me nā lawelawe 14.5.4 Nānā kālā 14.5.4 SWOT Analysis Key Development 14.5.6 Huadong Pharmaceutical Co., Ltd. 14.6.1 Main Overview 14.6.2 Business Description 14.6.3 Products and Services 14.6.4 Financial Overview 14.6.5 SWOT Analysis 14.6.6 Nā hana nui 14.7 Parkson Biotech Co., Ltd. 14.7.1 K Nā ʻike a pau 14.7.2 Hōʻike pāʻoihana 14.7.3 Nā huahana a me nā lawelawe 14.7.4 Nānā kālā 14.7.5 Nānā SWOT 14.7.6 Nā hana nui 14.8 TEOXANE laboratory 14.8.1 ʻOiaʻiʻo 14.8.2 Hōʻike pāʻoihana 14.8.3 Nā huahana a me nā lawelawe 14.8.85 Ke kālailai kālā 14.8.85 Ka nānā ʻana i ka nānā ʻana i ke kālā 14.9 ʻO ke keʻena ʻoihana BIOHA 14.9.1 Nā mea nui 14.9.2 ʻO ka wehewehe ʻoihana 14.9.3 Nā huahana a me nā lawelawe 14.9.4 Nānā kālā 14.9.4 Nānā kālā 14.9.4 .5 SWOT Analysis 14.9.6 Main Development 14.10 Prollenium Medical Technology 14.10.1 Main Facts 14.13.1 Products and Services 14.14.10 10.4 Financial Overview 14.10.5 SWOT Analysis 14.10.6 Main Development 15. Appendix, No ka ʻike hou aku e pili ana i kēia hōʻike. e ʻoluʻolu e kipa https://www.researchandmarkets.com/r/fjwmol
Research and Marketing Laura Wood, Senior Manager press@researchandmarkets.com US Eastern Time Office hours call +1-917-300-0470 US/Canada toll free number +1-800-526-8630 GMT Office hours call +353-1 -416 -8900 US Fax: 646-607-1904 Fax (Outside the US): +353-1-481-1716
Nānā i ka kikokikona kumu: https://www.prnewswire.com/news-releases/insights-on-the-dermal-fillers-global-market-to-2028—by-product-material-application-end-user- and -geography-301398176.html
ʻOiai ke alakaʻi ʻia nei ka mākeke e ka manaʻo pōkole i hoʻopili ʻia e ka ʻenekia o ka uku hoihoi ma ʻAmelika Hui Pū ʻIa, nā nūhou a me nā hoʻolimalima hoʻoulu ʻana, ua hoʻomaka ka nui o nā mea hoʻopukapuka e makaʻala e pili ana i ka mākeke bipi o kēia manawa mai Malaki 2020, pale a hōʻemi paha i nā mea he nui. ko lakou mau kulana loihi.Ke koho nei kekahi mau luna kālā ma ka Dow […]
No nā mea hoʻopukapuka e ʻimi nei i ka hoʻihoʻi maikaʻi loa, ʻo ka hoʻoholo ʻana i kahi e hoʻokomo ai i kā lākou hoʻopukapuka mua e iho mai i nā koho ʻelua.E hoʻokomo i kāu mau hua a pau i loko o kahi hīnaʻi nui, kūʻai i nā hui nui ma ka mākeke, kēlā mau hui trilion-dala i ʻike ʻia no kā lākou kumukūʻai kiʻekiʻe a me ka ulu paʻa-a kūʻai haʻahaʻa paha, a e ʻimi i kahi hui o nā kumu kūʻai haʻahaʻa i ka hui. .ʻO ke kumu pāʻoihana a me ka hiki ke piʻi nui.E pili ana i ka nui o kou makemake.Ke kuai ana
Ke holomua nei nā ʻoihana maʻamau, ʻoi aku ka nui o nā mea hoʻopukapuka liʻiliʻi liʻiliʻi.
E noi i kahi Kāleka Platinum American Express i kēia manawa a ʻae ʻia ma mua o ʻOkakopa 3, 2021, e hauʻoli i kahi makana hoʻokipa hoʻomaikaʻi a me kahi uku pāʻina HK5000 ma ke kau inoa ʻana a me ka hōʻaiʻē!
Hāʻawi ka waihona kālā hoʻokaʻawale i ka ballast no ka wā e hiki mai ana a hiki i kahi ʻāpana liʻiliʻi o kāu kapikala ke hoʻohana ʻia no nā kumu ulu a me nā hoʻopukapuka ʻoi aku ka nui.Ma ke ʻano o ka hāʻawi ʻana i ka waiwai me nā mea hoʻopukapuka, ʻo Unilever (NYSE: UL), Altria Group (NYSE: MO), a me Leggett (NYSE: LEG) ʻo ia nā ʻāpana blue-chip.No ka laʻana, uku ʻo Unilever i $2.02 no kēlā me kēia makahiki, ʻo ia hoʻi, pono ʻoe e kūʻai i 495 mau ʻāpana, a kokoke i $26,000 ke kumukūʻai no ke kūʻai ʻana i ke kumukūʻai ma ke kumu kūʻai ʻoi aku ma mua o $52.
Ua hui pū ʻo Cowen Managing Director Kevin Kopelman iā Yahoo Finance e wāwahi i ka ulu ʻana o Airbnb, kahi i alakaʻi ai i ka hoʻomaikaʻi ʻana iā Cowen, nā hōʻike e kākoʻo ana i kēia hoʻonui, a me ke kūlana hoʻokūkū o ka ʻoihana hōkele.
E noi no ka American Express Explorer™ Credit Card ma aneʻi e ʻoliʻoli i ka uku makahiki mua a me 3 mau manawa i nā helu manuahi ʻole, ke kūʻai akamai a i ʻole ka hoʻopau ʻana i nā makana like ʻole no ka hoʻolimalima!
Ma hope o ka mālama ʻana o ka mea loiloi Barclays ʻo Kannan Venkateshwar i ka helu kaulike ma luna o ke kumukūʻai a hoʻohaʻahaʻa i kāna kumu kūʻai mai $34 a i $30, hāʻule ke kumukūʻai o AT&T (NYSE: T) i ka Pōʻakahi.Ua kuhikuhi ʻo Barclays analysts ma muli o ka paʻakikī o ka hoʻokō waiwai o Discovery Inc (NASDAQ: DISCA), e hui pū ʻo AT&T me kāna ʻoihana media.I ka manawa o ka hoʻokuʻu ʻia ʻana, ʻo AT&T kekahi o nā kumukūʻai kiʻekiʻe ʻekolu ma Stocktwits.E hoʻolaha ʻo AT&T i kāna mau hopena kālā ʻekolu hapaha
Hāʻawi kā mākou mau mea kōkua ʻekolu i ʻekolu COVID-19 stocks, e piʻi aʻe inā e puka mai mākou mai ka maʻi maʻi.
ʻO ka hōʻike hana iPhone a Apple i hāʻule i ka wā e hiki mai ana.ʻOiai nā hana ikaika i hana ʻia e Upstart a me nā poʻe hou aku, ua hoʻi hou ka mākeke a pani maikaʻi ʻole.
Ke noi nei nā mea kūʻai i koho ʻia no 12-36 manawa uku a ʻo ka nui he $200,000 a ʻoi aʻe paha, a ua hoʻonohonoho ʻia kahi uku uku makahiki maoli o 4%!E hōʻaiʻē e hōʻaiʻē?E loaʻa pū i kahi hōʻaiʻē maikaʻi!
Ke hoʻomau nei ʻo ARK Invest e hoʻohui i kekahi o nā pendants nui o CEO Casey Wood, me nā pendants i hāʻule ma kahi o 60% mai ka piʻi ʻana i Pepeluali.
ʻO nā moʻolelo ʻakaʻaka (a i ʻole kaumaha, e pili ana i kou nānā ʻana iā ia) e hoʻoikaika iā ʻoe (manaʻolana) e nānā pālua i kāu kōpili i ko mākou komo ʻana i 2022.
Ua ʻōlelo ka mea hana chip mobile ua ʻae kāna papa alakaʻi i kahi papahana kūʻai hou $ 10 biliona, e hoʻokō koke ʻia.
Mai kēia manawa a hiki i ʻOkakopa 24, 2021, e hāʻawi ʻia ana nā mea koho nui a Ernst & Young me nā mea hale a me nā lole wahine ma ke kumukūʻai a hiki i 20%, e hoʻomaka koke ana i nā mea punahele!
Hōʻike kekahi palapala ʻaʻole e emi iho ka puunaue hui o nā hui kūʻokoʻa ʻelua ma mua o ka puʻunaue ma mua o ka māhele ʻana o IBM.
(Bloomberg) -Ua hōʻike ʻo Bloomberg e ʻoki paha ka ʻenehana ʻenehana i kāna pahuhopu 2021 iPhone 13 ma muli o ka hemahema o ka chip, a haʻi i ka poʻe i kamaʻāina i kēia mea e ʻōlelo ana ua hāʻule nā mea kūʻai aku o Apple i ka Pōʻakolu.Ua lilo ka pōʻai haʻahaʻa i mea hana kiʻi e hōʻike ana i ka laina mua o ka hakakā ʻana ma Kentucky, USA.Ua like ia me ka Waldorf Astoria ma New York e hana hou ana i ka nani, e lilo ana i hōʻailona o ka Chinese Overreach tycoon ma hope o ka hāʻule ʻana o ka waiwai i ka wā pilikia.
Ma hope o ka hoʻokiʻekiʻe ʻana o nā ʻenehana olakino i kā lākou mau wānana kālā piha makahiki, ua piʻi ka InMode (NASDAQ: INMD) i ka 8.6% i ka Pōʻalua.No laila, manaʻo ʻo InMode i ka loaʻa kālā o $93 i ka hapaha ʻekolu.
Ma ka pūnaewele a i ʻole ka hui kumu kumu ʻoihana kino, kūpono no ka hoʻopaʻa inoa ʻoihana āpau, nā hana moʻomeheu manuahi i kēlā me kēia manawa, ʻike i nā kuʻuna aupuni like ʻole, Prince Tuen Mun Yuen Long Tin Shui Wai Sha Tin Wind Class!
ʻO kēia biotech stock, ka mea i loaʻa wale i ka volatility, ʻo ia ka mea punahele o nā mea kūʻai aku kūʻai ma muli o ka hiki ke hoʻopaʻa pōkole.
ʻO Aadil Zaman, ka hoa o ka Wall Street Alliance Group, i hoʻolaha ola ʻia ma Yahoo Finance, e kūkākūkā ana i nā manaʻolana no ke kolu o ka makahiki loaʻa kālā, nā panakō nui a me ka hoʻokele waiwai.
Ka manawa hoʻouna: ʻOkakopa-13-2021